Patent Assignment
Reel/Frame 053122/0081
Change of Address for Assignee
Recorded: 2020-07-02
Pages: 35
Assignor
OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KFT
Executed: 2020-05-22
Assignee
OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KFT
LEVENTE UTCA 14/A, CSOMAD, 2161, HUNGARY
Covered Properties
(45)
Osmotic Device Containing Pseudoephedrine and an H1ANTAGONIST
Osmotic Device Containing Venlafaxine and an Anti-Psychotic Agent
Osmotic Device Having a Preformed Passageway That Increases in Size
Osmotic Device Within an Osmotic Device
Drug Delivery Device Containing Oseltamivir and an H1 Antagonist
Laser Drilling System and Method
Osmotic Device Containing Venlafaxine and an Anti-Psychotic Agent
Drug Delivery Device Containing Neuraminidase Inhibitor and an H1 Antagonist
Osmotic Device Containing Pseudoephedrine and an H1 Antagonist
Rupturing Controlled Release Device Having a Preformed Passageway
Laser Drilling System and Method
Osmotic Device Containing a Venlafaxine Salt and a Salt Having an Ion in Common
Osmotic Device Containing Amantadine and an Osmotic Salt
Dual Controlled Release Osmotic Device
Dual Controlled Release Dosage Form
Triple Combination Release Multi-Layered Tablet
Rupturing Controlled Release Device Comprising a Subcoat
Osmotic Device Containing Amantadine and an Osmotic Salt
Dual Controlled Release Dosage Form
Triple Combination Release Multi-layered Tablet
Controlled Release Dosage Form
Controlled Release Dosage Form
Controlled Release Dosage Form
Dose-Dumping Resistant Controlled Release Dosage Form
Patent:
9,707,217 →
Application:
15/424,134 →
Controlled Release Dosage Form
Dose-Dumping Resistant Controlled Release Dosage Form
Patent:
9,827,234 →
Application:
15/624,075 →
Dose-Dumping Resistant Controlled Release Dosage Form
Patent:
9,855,258 →
Application:
15/624,209 →
Dose-Dumping Resistant Controlled Release Dosage Form
Controlled Release Dosage Form with Enhanced Pharmacokinetics
Controlled Release Dosage Form
Controlled Release Dosage Form
Composition and Method for Treating Neurological Disease
Patent:
10,213,393 →
Application:
15/898,143 →
Composition and Method for Treating Neurological Disease
Patent:
10,213,394 →
Application:
15/898,148 →
Controlled Release Dosage Form
Controlled Release Dosage Form
Controlled Release Dosage Form with Enhanced Pharmacokinetics
Controlled Release Dosage Form
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Dose-Dumping Resistant Controlled Release Dosage Form
Controlled Release Dosage Form
Controlled Release Dosage Form
Controlled Release Dosage Form
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Transfer of Right to Make, Use, Sell, Offer to Sell for Nifedipine
Feb 4, 2010
From: OSMOTICA CORP.
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 023892/0674 →
Transfer of Right to Make, Use, Sell, Offer to Sell for Oxybutynin
Feb 4, 2010
From: OSMOTICA CORP.
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 023892/0723 →
Corrective Assignment to Correct the Name of the Assignee on the Recordation Sheet to Osmotica Pharmaceutical Corp. Previously Recorded on Reel 023892 Frame 0674. Assignor(S) Hereby Confirms the Transfer of Right to Make, Use, Sell, Offer to Sell for Nifedipine.
Feb 8, 2010
From: OSMOTICA CORP.
To: OSMOTICA PHARMACEUTICAL CORP.
Reel/Frame 023905/0766 →
Corrective Assignment to Correct the Name of the Assignee on the Recordation Sheet to Osmotica Pharmaceutical Corp. Previously Recorded on Reel 023892 Frame 0723. Assignor(S) Hereby Confirms the Transfer of Right to Make, Use, Sell, Offer to Sell for Oxybutynin.
Feb 8, 2010
From: OSMOTICA CORP.
To: OSMOTICA PHARMACEUTICAL CORP.
Reel/Frame 023905/0752 →
Assignee Change of Address
Nov 20, 2013
From: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 031692/0741 →
Security Interest
Feb 3, 2016
From: OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KORLÁTOLT FELELOSSÉGU TÁRSASÁG
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 037656/0777 →
Security Interest
Aug 27, 2021
From: AVION PHARMACEUTICALS, LLC; SOVEREIGN PHARMACEUTICALS, LLC; ACELLA HOLDINGS, LLC
To: CIBC BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 057310/0385 →
Release of Security Interest
Aug 28, 2021
From: CIT BANK, N.A., AS COLLATERAL AGENT
To: OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KORLÁTOLT FELELOSSÉGU TÁRSASÁG
Reel/Frame 057319/0873 →
Assignment of Assignor's Interest
Sep 28, 2021
From: OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KORLÁTOLT FELELOSSÉGU TÁRSASÁG
To: ACELLA HOLDINGS, LLC
Reel/Frame 057627/0758 →